This Month in Psychopharmacology

Glutamatergic Modulation for Psychiatric Disorders

he science behind the role of glutamatergic neurotransmissions role...

Read More

The Role of Inflammation in Mental Health

Inflammation triggers chemical reactions in the body that can direc...

Read More

NEI Congress Scientific Poster Session

Presented below are the winners of the 2024 NEI Congress Young Inve...

Read More

Adult ADHD and Dementia

Every year NEI Fall Congress kicks off with multiple pre-conference...

Read More

Child and Adolescent Psychiatry Academy

Every year NEI Fall Congress kicks off with multiple pre-conference...

Read More

Positive Results For Lumateperone in the Prevention of Relapse in Adult Patients with Schizophrenia

Positive results have been announced from phase III study evaluatin...

Read More

Cognitive Dysfunction Across Mental Disorders and its Relation to Suicidality

A recent study examined the relationship between cognitive function...

Read More

October Is ADHD Awareness Month

October is ADHD Awareness Month. The goal of ADHD Awareness Month i...

Read More

Medication-Induced Weight Change Across Common Antidepressant Treatments

While antidepressants rank among the most frequently prescribed dru...

Read More

Inflammatory Biomarkers and Risk of Psychiatric Disorders

A recent study investigates whether certain inflammatory markers i...

Read More

FDA Approves First Muscarinic Agonist for Schizophrenia

The U.S. Food and Drug Administration has approved xanomeline-tros...

Read More

Poor Sleep Associated with Poorer Antidepressant Response

Poor sleep is common in treatment-resistant late-life depression an...

Read More